Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.17 USD | -22.87% | -4.79% | +21.37% |
04-15 | Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target | MT |
04-15 | William Blair Starts LENZ Therapeutics With Outperform Rating | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT |
---|
Technical Rankings Surperformance
- Stock Market
- Equities
- LENZ Stock
- GRPH Stock
- Charts LENZ Therapeutics, Inc.
- Comparison Chart